Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Non-infectious, Intermediate-, Posterior- or Pan-uveitis

NCT05384249 is registered in ClinicalTrials.gov with ACELYRIN Inc. as lead sponsor.

NCT NCT05384249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05384249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects with Non-infectious, Intermediate-, Posterior- or Pan-uveitis
Lead sponsor
ACELYRIN Inc.
Phase
Phase 2
Overall status
Terminated
Start date
August 23, 2022
Completion date
February 7, 2025
Enrollment
96 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis